PL348049A1 - Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications - Google Patents
Pyridinium derivatives for the treatment of diabetic and aging−related vascular complicationsInfo
- Publication number
- PL348049A1 PL348049A1 PL99348049A PL34804999A PL348049A1 PL 348049 A1 PL348049 A1 PL 348049A1 PL 99348049 A PL99348049 A PL 99348049A PL 34804999 A PL34804999 A PL 34804999A PL 348049 A1 PL348049 A1 PL 348049A1
- Authority
- PL
- Poland
- Prior art keywords
- diabetic
- aging
- treatment
- vascular complications
- related vascular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN827CA1999 | 1999-10-06 | ||
| PCT/IB1999/001687 WO2001025209A1 (en) | 1999-10-06 | 1999-10-15 | Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL348049A1 true PL348049A1 (en) | 2002-05-06 |
Family
ID=11084921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99348049A PL348049A1 (en) | 1999-10-06 | 1999-10-15 | Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1220843A1 (xx) |
| JP (1) | JP2003511370A (xx) |
| CN (1) | CN1329597A (xx) |
| AU (1) | AU5994499A (xx) |
| BR (1) | BR9915962A (xx) |
| CA (1) | CA2351075A1 (xx) |
| CZ (1) | CZ20011808A3 (xx) |
| HK (1) | HK1044336A1 (xx) |
| HU (1) | HUP0301687A2 (xx) |
| MX (1) | MXPA02003496A (xx) |
| PL (1) | PL348049A1 (xx) |
| WO (1) | WO2001025209A1 (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002067851A2 (en) * | 2000-12-29 | 2002-09-06 | Alteon, Inc. | Method for treating fibrotic diseases or other indications iiic |
| ATE299496T1 (de) * | 2001-03-21 | 2005-07-15 | Torrent Pharmaceuticals Ltd | Pyridiniumverbindungen zur behandlung von age- relatierten krankheiten |
| CZ303214B6 (cs) * | 2001-03-21 | 2012-05-30 | Torrent Pharmaceuticals Ltd | Pyridiniová sloucenina, zpusob její výroby, její použití, farmaceutický prostredek ji obsahující, zpusob jeho výroby a jeho použití |
| ES2231685T3 (es) * | 2001-04-05 | 2005-05-16 | Torrent Pharmaceuticals Ltd | Compuestos heterociclicos para complicaciones vasculares diabeticas y relacionadas con la edad. |
| HUP0104832A2 (en) * | 2001-10-19 | 2003-08-28 | Torrent Pharmaceuticals Ltd | Cosmetic composition and method |
| GB0328314D0 (en) * | 2003-12-05 | 2004-01-07 | Univ Bath | Therapeutics |
| WO2007132179A2 (en) * | 2006-05-15 | 2007-11-22 | University Of Bath | Therapeutics comprising pyridinium derivatives |
| JP2009155315A (ja) * | 2007-12-26 | 2009-07-16 | Fujiyakuhin Co Ltd | 注射剤 |
| KR20120018185A (ko) * | 2009-05-07 | 2012-02-29 | 토렌트 파마슈티칼스 리미티드 | 당뇨병 치료에 유용한 피페리딘 유도체 |
| EP2903614B1 (en) * | 2012-10-05 | 2021-09-29 | Sphaera Pharma Pte. Ltd | Novel compounds, their synthesis and their uses |
| EP3280711A1 (en) * | 2015-04-08 | 2018-02-14 | Torrent Pharmaceuticals Limited | Novel pyridinium compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH335521A (de) * | 1955-06-02 | 1959-01-15 | Cilag Ag | Verfahren zur Herstellung neuer quaternärer Salze |
| US3318787A (en) * | 1964-02-07 | 1967-05-09 | Udylite Corp | Electrodeposition of zinc |
| US3823076A (en) * | 1972-05-23 | 1974-07-09 | Du Pont | Zinc electroplating additive |
| JPS5936247B2 (ja) * | 1977-04-20 | 1984-09-03 | ティーディーケイ株式会社 | 電気的表示装置 |
| JPS55138742A (en) * | 1979-04-17 | 1980-10-29 | Fuji Photo Film Co Ltd | Silver halide emulsion developing method |
| JPH0253759A (ja) * | 1988-08-18 | 1990-02-22 | Hamari Yakuhin Kogyo Kk | 新規な４級アンモニウム化合物 |
| DD275872A1 (de) * | 1988-09-27 | 1990-02-07 | Univ Dresden Tech | Verfahren zur herstellung von 5h-pyrido[1',2':1,2]imidazo[5,4-c]chinolin-6-onen |
| MX9705449A (es) * | 1995-01-18 | 1998-02-28 | Alteon Inc | Uso de compuestos de tiazolio para evitar y revertir la formacion de productos finales de glicosilacion avanzada. |
| CA2285556A1 (en) * | 1997-04-04 | 1998-10-15 | Smithkline Beecham Corporation | Calcilytic compounds |
-
1999
- 1999-10-15 BR BR9915962-7A patent/BR9915962A/pt not_active IP Right Cessation
- 1999-10-15 EP EP99974071A patent/EP1220843A1/en not_active Withdrawn
- 1999-10-15 CA CA002351075A patent/CA2351075A1/en not_active Abandoned
- 1999-10-15 JP JP2001528155A patent/JP2003511370A/ja active Pending
- 1999-10-15 HU HU0301687A patent/HUP0301687A2/hu unknown
- 1999-10-15 CN CN99814055A patent/CN1329597A/zh active Pending
- 1999-10-15 CZ CZ20011808A patent/CZ20011808A3/cs unknown
- 1999-10-15 MX MXPA02003496A patent/MXPA02003496A/es unknown
- 1999-10-15 WO PCT/IB1999/001687 patent/WO2001025209A1/en not_active Application Discontinuation
- 1999-10-15 PL PL99348049A patent/PL348049A1/xx not_active Application Discontinuation
- 1999-10-15 AU AU59944/99A patent/AU5994499A/en not_active Abandoned
-
2002
- 2002-08-12 HK HK02105890.8A patent/HK1044336A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5994499A (en) | 2001-05-10 |
| MXPA02003496A (es) | 2005-06-20 |
| CA2351075A1 (en) | 2001-04-12 |
| HK1044336A1 (zh) | 2002-10-18 |
| JP2003511370A (ja) | 2003-03-25 |
| WO2001025209A1 (en) | 2001-04-12 |
| EP1220843A1 (en) | 2002-07-10 |
| BR9915962A (pt) | 2003-01-07 |
| HUP0301687A2 (hu) | 2003-08-28 |
| CN1329597A (zh) | 2002-01-02 |
| CZ20011808A3 (cs) | 2001-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1781901A (en) | Expandable venous cannula and method of use | |
| AU5056300A (en) | Devices and compounds for treating arterial restenosis | |
| AU5788300A (en) | Medical treatment method and kit | |
| HK1048949A1 (en) | Method and composition for the treatment of scars | |
| AU5774100A (en) | Method and apparatus for the noninvasive determination of arterial blood pressure | |
| MXPA01009415A (es) | COMPOSICION DE ACIDO ASCORBICO Y METODO PARA TRATAMIENTO DE PIEL DAnADA O ENVEJECIDA. | |
| AU4171500A (en) | Flupirtine in the treatment of fibromyalgia and related conditions | |
| AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
| AU4717301A (en) | Catheter assembly and method of use | |
| HUP0104116A3 (en) | Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof | |
| EP1305018A4 (en) | METHODS AND COMPOUNDS FOR PROPHYLAXIS AND / OR TREATMENT OF DIABETES AND GLUCOSE DEREGULATION | |
| PL348049A1 (en) | Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications | |
| HUP0200738A3 (en) | Method of the treatment of incontinence | |
| AU1794801A (en) | Method for treatment and prevention of physiological shock | |
| AU1321101A (en) | Cholesterol lowering and blood lipids lowering composition | |
| AU2001244461A1 (en) | Venous line catheter and method of operating the same | |
| EP1089731A4 (en) | COMPOSITIONS AND METHOD FOR TREATING INCREASED BLOOD CHOLESTEROL LEVELS | |
| AU2420101A (en) | Method and composition for the treatment of pain | |
| AU2566201A (en) | Compounds and methods for the treatment of pain | |
| AU6648200A (en) | Method and composition for preventing or treating adverse physiological effects associated with cardiac disease | |
| HUP0300043A3 (en) | Method and composition for the treatment of pain | |
| IL150208A0 (en) | Compound and method for the treatment of pain | |
| AU2420201A (en) | Compounds and methods for the treatment of pain | |
| AU2899099A (en) | Composition for treatment and prevention of coronary artery disease | |
| AU2227501A (en) | Protein-prefilled syringe preparation and method of stabilizing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |